Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "antioxidant pathway via thymoquinone activity" refers to the array of cellular antioxidant and cytoprotective mechanisms that are directly or indirectly modulated by the natural product thymoquinone. Thymoquinone acts as a free radical scavenger and modulates the activity of both enzymatic and non-enzymatic components of the oxidative defense system. These effects are mediated through direct chemical interactions (e.g., conjugation with glutathione), upregulation of endogenous antioxidant enzymes such as superoxide dismutase and glutathione peroxidase (often via activation of Nrf2), and inhibition of pro-inflammatory and pro-oxidant signaling pathways (e.g., NF-κB, COX-2, STAT3). Thymoquinone’s antioxidant actions are associated with reductions in lipid peroxidation, DNA damage, and enhancement of cellular resistance to oxidative stress. While widely considered protective in preclinical models of cancer, inflammation, neurodegeneration, and liver injury, these are not properties of a single molecular target but of a broader pharmacological effect driven by thymoquinone’s multi-target actions[1][3][5][6][7][8]. Note: Since the term describes a pharmacological activity rather than a specific molecular entity, it should not be considered a canonical drug target or receptor but rather a description of a bioactive pathway ensemble.
Scavenging of reactive oxygen species by thymoquinone and its metabolite conjugates[1][3][8]. Induction of antioxidant enzymes via Nrf2 activation[8]. Inhibition of pro-inflammatory pathways (NF-κB, COX-2, STAT3)[2][4][7][8]. Modulation of cell death (apoptosis) through ROS management[2][8]. Reduction of lipid peroxidation and DNA damage[1][5]. Enhancement of glutathione (GSH) and other endogenous antioxidants[3][5][7].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymoquinone-modulated antioxidant pathways.